The Race for a Cure

from Axios Re:Cap Hosted by Axios

Biotech company Moderna has become the first to bring a possible coronavirus vaccine to clinical trials. Dan is joined by Axios health care business reporter Bob Herman to lay out the best case scenario timeline for the company’s vaccine and what makes it different from a typical vaccine. PLUS: Amazon staffs up and old Hollywood turns to streaming.

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

The Race for a Cure

0:00 11:08

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

Small Caps Canada Small Caps Canada The Small Caps podcast keeps stock market investors informed with the latest news by interviewing directors of Canadian listed small cap companies and financial market analysts

Frequently asked questions

How long is this episode of Axios Re:Cap?

This episode is 11 minutes long.

When was this Axios Re:Cap episode published?

This episode was published on March 17, 2020.

Can I download this Axios Re:Cap episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.